We advised the underwriters on the SEC-registered equity offering

Davis Polk advised the representatives of the several underwriters in connection with the $251.3 million SEC-registered offering of 3,750,000 shares of Class A common stock of Seer, Inc., of which 1,650,000 shares of Class A common stock were issued and sold by Seer and 2,100,000 shares of Class A common stock were sold by the selling shareholders. The Class A common stock is listed on the Nasdaq Global Select Market under the symbol “SEER.”

Based in Redwood City, California, Seer aims to enable exceptional scientific outcomes by commercializing transformative products for researchers to unlock deep, unbiased biological information. Seer’s initial product, the Proteograph Product Suite, will leverage proprietary engineered nanoparticle technology to provide unbiased, deep, rapid and large-scale access across the proteome.

The Davis Polk corporate team included partner Alan F. Denenberg and associates Jacqueline Marino and Daniel Reichert. The intellectual property and technology transactions team included counsel Bonnie Chen and associate Marisa Elena Bannon. The tax team included partner Mario J. Verdolini and associate Rebecca A. Rosen. Counsel Gregory D. Hughes provided executive compensation advice. Counsel Marcie A. Goldstein provided FINRA advice. Members of the Davis Polk team are based in the Northern California and New York offices.